Eating disorders, like Anorexia Nervosa and Bulimia, are reaching epidemic proportions. They have been around for a long time, but they have increased substantially in recent times. One study found that the incidence of anorexia nervosa is around 8 per 100,000 persons per year, with "an upward trend has been observed in the incidence of anorexia nervosa in the past century till the 1970s" with "the most substantial increase was among females aged 15-24 years, for whom a significant increase was observed from 1935 to 1999".
This is, of course, the period when pharmaceutical drugs became more widely available and consumed, perhaps something that the conventional medical establishment wants to ignore as a possible cause of this increase.
And the incidence of eating disorders continues to rise, alarmingly. In 2020, NHS Digital date (England) showed that hospital admissions for eating disorders rose by 37% across all age groups over the previous two years. They showed that there were 19,040 admissions for eating disorders in 2018/19, up from 16,558 the year before, and 13,885 in 2016/17. The most common age for patients with anorexia was 13 to 15. These British figures are mirrored across the entire pharmaceutical drug-taking world!
So what is pharmaceutical medicine, and the NHS doing about this rising tide of illness?
Research published in the American Journal of Public Health in 2019 (doi: 10.2105 / AJPH. 2019. 305390), found that young women who take diet pills and laxatives to reduce their weight are more likely to suffer an eating disorder just a year or so later.
So an important cause of the disease is ignored, and the disease continues to grow and grow. Conventional medicine bemoans increased patient demands on resources, their inability to cope with this increased demand, and seek increased resources to enable them to cope with the problem.
This is, of course, the period when pharmaceutical drugs became more widely available and consumed, perhaps something that the conventional medical establishment wants to ignore as a possible cause of this increase.
And the incidence of eating disorders continues to rise, alarmingly. In 2020, NHS Digital date (England) showed that hospital admissions for eating disorders rose by 37% across all age groups over the previous two years. They showed that there were 19,040 admissions for eating disorders in 2018/19, up from 16,558 the year before, and 13,885 in 2016/17. The most common age for patients with anorexia was 13 to 15. These British figures are mirrored across the entire pharmaceutical drug-taking world!
So what is pharmaceutical medicine, and the NHS doing about this rising tide of illness?
- They are spending money on it of course - more and more.
- They diagnose it mainly as a psychological illness, which means more counselling, more 'talking cures', and demands for more mental health provision
- And they come up with a number of reasons for the increase in eating disorders
Research published in the American Journal of Public Health in 2019 (doi: 10.2105 / AJPH. 2019. 305390), found that young women who take diet pills and laxatives to reduce their weight are more likely to suffer an eating disorder just a year or so later.
- Laxatives increased the risk 5-fold and diet pills by 80%. These pills are easy to purchase over-the-counter in pharmacies or online.
- Conventional medicine will not 'wake up' as it is routinely and vigorously opposed to any suggestion that the drugs and vaccines they prescribe to patients cause serious illness and disease.
- And the drugs that cause eating disorders will not be banned because the powerful pharmaceutical industry will not allow them to be banned.
So an important cause of the disease is ignored, and the disease continues to grow and grow. Conventional medicine bemoans increased patient demands on resources, their inability to cope with this increased demand, and seek increased resources to enable them to cope with the problem.
Conventional medicine is an on-going, self-fulfilling disaster!
